NCT02991651 2025-05-14Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLCIo TherapeuticsPhase 1 Terminated12 enrolled
NCT00640978 2025-05-01Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerM.D. Anderson Cancer CenterPhase 2 Terminated16 enrolled 4 charts